EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of oxyresveratrol, a food-as-medicine substrate, as a novel EPI that targets the RND efflux pumps of Serratia surfactantfaciens sp. nov. YD25 T

Fuqiao Liu iD, Xiaoyu Wei, Yaoyu Lou, Yurong Wang, Danlu Zhang, Bing Cao, Chun Su, Yan Sun iD, Zhi Li iD

Microbiology Spectrum · 02.06.2026 · 14 (6)

DOI: 10.1128/spectrum.02185-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.06.2026. Verfasst von Fuqiao Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Shaanxi Normal University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Stilbenes, Bacterial Proteins, Membrane Transport Proteins. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Key Research and Development Program of Shaanxi, Natural Science Basic Research Program of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serratia marcescens is an opportunistic pathogen with increasing drug resistance. Serratia surfactantfaciens sp. nov. YD25 T , a novel strain with multidrug resistance, shares similarities with S. marcescens . This study investigated the resistance mechanisms of YD25, with a focus on efflux pumps and their regulators. Bioinformatics analysis revealed numerous resistance genes in YD25, including five RND-type efflux pumps, SdeAB, SdeCDE, SdeGH, SdePQ-OmsA, and SdeXY. Oxyresveratrol, evernic acid, and morin were identified as efflux pump inhibitors, with oxyresveratrol showing the strongest effect targeting SdeXY and sensitizing YD25 to seven antibiotics. Among the RND pumps, SdeXY and SdeCDE are constitutively expressed and are regulated negatively by AcrR and positively by BaeSR, respectively. YD25 harbors four global regulators, including RamA, SoxS, Rob, and a novel Roblike protein. The deletion of these genes downregulated SdeXY and SdeCDE, increasing antibiotic susceptibility and confirming their role as positive regulators. Rob and Roblike exhibited functional overlap. This study elucidates the RND efflux pumps and their regulators in YD25, advancing the understanding of Serratia resistance mechanisms. Oxyresveratrol, a newly identified SdeXY inhibitor, offers potential for combination therapies against drug-resistant Serratia . IMPORTANCE This study reveals novel insights into Serratia surfactantfaciens YD25’s multidrug resistance, identifying RND efflux pumps (e.g., SdeXY and SdeCDE) as key drivers. The key discoveries include the following: (i) oxyresveratrol, a natural compound functioning as an SdeXY efflux pump inhibitor, effectively reverses bacterial resistance, thereby restoring the clinical utility of antibiotics that had been rendered nearly obsolete by drug resistance, and (ii) YD25 uniquely possesses two Rob regulators (Rob and Roblike). Despite their different origins, both positively regulate RND pump function—a finding reported for the first time in bacteria. These findings highlight the potential of natural efflux pump inhibitors against Serratia infections while uncovering an unusual regulatory redundancy in bacterial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsStilbenesBacterial ProteinsMembrane Transport ProteinsPlant ExtractsSerratiaDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsGene Expression Regulation, Bacterial

Stichwörter der Autor:innen

RNDRobSerratiaefflux pump inhibitorfood-as-medicine substrateoxyresveratrol

Substanzen

Anti-Bacterial AgentsStilbenesBacterial ProteinsMembrane Transport Proteinspuag-haadPlant Extracts

Autor:innen und Institutionen

  • College of Life Sciences, Shaanxi Normal University, Xi'an, People's Republic of China.

ORCID-Profile: Fuqiao Liu, Yan Sun, Zhi Li

Förderung

  • Fundamental Research Funds for the Central Universities
  • Key Research and Development Program of Shaanxi
  • Natural Science Basic Research Program of Shaanxi Province

Zitieren

APA

Liu, F., Wei, X., Lou, Y., Wang, Y., Zhang, D., Cao, B., Su, C., Sun, Y., & Li, Z. (2026). Identification of oxyresveratrol, a food-as-medicine substrate, as a novel EPI that targets the RND efflux pumps of Serratia surfactantfaciens sp. nov. YD25 T. Microbiology Spectrum, 14(6). https://doi.org/10.1128/spectrum.02185-25

Vancouver

Liu F, Wei X, Lou Y, Wang Y, Zhang D, Cao B, et al. Identification of oxyresveratrol, a food-as-medicine substrate, as a novel EPI that targets the RND efflux pumps of Serratia surfactantfaciens sp. nov. YD25 T. Microbiology Spectrum. 2026;14(6). doi:10.1128/spectrum.02185-25

BibTeX
@article{Liu2026,
  author = {Liu, Fuqiao and Wei, Xiaoyu and Lou, Yaoyu and Wang, Yurong and Zhang, Danlu and Cao, Bing and Su, Chun and Sun, Yan and Li, Zhi},
  title = {Identification of oxyresveratrol, a food-as-medicine substrate, as a novel EPI that targets the RND efflux pumps of Serratia surfactantfaciens sp. nov. YD25 T},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1128/spectrum.02185-25}
}
Kostenlos starten →